These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7544246)

  • 1. Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides.
    Amara A; Constans J; Chaugier C; Sebban A; Dubourg L; Peuchant E; Pellegrin JL; Leng B; Conri C; Geffard M
    Clin Exp Immunol; 1995 Aug; 101(2):233-8. PubMed ID: 7544246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies.
    Ben Mansour R; Lassoued S; Elgaied A; Haddouk S; Marzouk S; Bahloul Z; Masmoudi H; Attia H; Aïfa MS; Fakhfakh F
    Scand J Rheumatol; 2010 May; 39(3):247-53. PubMed ID: 20429675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
    J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
    Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
    Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
    Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):423-30. PubMed ID: 11814236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against lamin C, NA14 and CK15 in primary vasculitides or autoimmune diseases with secondary vasculitis.
    Kubuschok B; Preuss KD; Baier-Thoenes K; Regitz E; Thurner L; Assmann G; Pfreundschuh M
    Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S60-9. PubMed ID: 27214601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
    Svenungsson E; Engelbertsen D; Wigren M; Gustafsson JT; Gunnarsson I; Elvin K; Jensen-Urstad K; Fredrikson GN; Nilsson J
    Clin Exp Immunol; 2015 Sep; 181(3):417-26. PubMed ID: 25959453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls.
    Lourdudoss C; Ajeganova S; Frostegård J
    Clin Exp Rheumatol; 2018; 36(3):428-433. PubMed ID: 29745894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
    Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
    Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
    Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of natural IgM autoantibodies to oxidative stress-related neo-epitopes on apoptotic cells in newborns of mothers with anti-Ro autoimmunity.
    Grönwall C; Clancy RM; Getu L; Lloyd KA; Siegel DL; Reed JH; Buyon JP; Silverman GJ
    J Autoimmun; 2016 Sep; 73():30-41. PubMed ID: 27289167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
    Wisnieski JJ; Jones SM
    J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotypes of autoantibodies against differentially expressed novel malondialdehyde-modified peptide adducts in serum of Taiwanese women with rheumatoid arthritis.
    Liao CC; Chang YS; Cheng CW; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lin YF; Lin HT; Lu YY; Lin CY
    J Proteomics; 2018 Jan; 170():141-150. PubMed ID: 28870784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating antibodies recognizing malondialdehyde-modified proteins in healthy subjects.
    Vay D; Parodi M; Rolla R; Mottaran E; Vidali M; Bellomo G; Albano E
    Free Radic Biol Med; 2001 Feb; 30(3):277-86. PubMed ID: 11165874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases.
    Cuchacovich M; Gatica H; Pizzo SV; Gonzalez-Gronow M
    Clin Exp Rheumatol; 2001; 19(6):673-80. PubMed ID: 11791639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis and other rheumatic conditions.
    Mikuls TR; Duryee MJ; England BR; Anderson DR; Hearth-Holmes M; Su K; Michaud K; Payne JB; Sayles H; Hunter C; McGowan JD; Klassen LW; Thiele GM
    Int Immunopharmacol; 2018 Mar; 56():113-118. PubMed ID: 29414640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
    Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
    Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.
    Saxena R; Sturfelt G; Nived O; Wieslander J
    Ann Rheum Dis; 1994 Oct; 53(10):659-65. PubMed ID: 7979578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.